Taurohyodeoxycholic Acid

A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
1mg

￥275.00

220.00

- +
5mg

￥1250.00

1000.00

- +
10mg

￥2237.00

1790.00

- +
25mg

￥4862.00

3890.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

Taurohyodeoxycholic acid (THDCA) is a taurine-conjugated form of the secondary bile acid hyodeoxycholic acid . THDCA decreases the size and weight of human gallstones in vitro. It increases bile flow, biliary cholesterol secretion, and biliary lipid secretion in rats. Co-administration of THDCA with taurochenodeoxycholic acid prevents TCDCA-induced hepatotoxicity, increasing bile flow as well as biliary acid and phospholipid secretion in rats. THDCA also reduces myeloperoxidase activity, expression of TNF-α and IL-6, and colonic damage in a mouse model of TNBS-induced ulcerative colitis.